Stocks and Investing
Stocks and Investing
Fri, October 28, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derik De Bruin Downgraded (WST) to Hold and Decreased Target to $250 on, Oct 28th, 2022
Derik De Bruin of B of A Securities, Downgraded "West Pharmaceutical Services, Inc." (WST) to Hold and Decreased Target from $385 to $250 on, Oct 28th, 2022.
Derik has made no other calls on WST in the last 4 months.
There is 1 other peer that has a rating on WST. Out of the 1 peers that are also analyzing WST, all agrees with Derik's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jacob Johnson of "Stephens & Co." Maintained at Hold with Increased Target to $345 on, Friday, July 29th, 2022
Contributing Sources